MSB 3.06% $1.01 mesoblast limited

They are a potential rival with claims of being able to...

  1. 102 Posts.
    lightbulb Created with Sketch. 252
    They are a potential rival with claims of being able to manufacture MSCs. The have approval for a stage 1 trial with FDA since mid May 2020.
    https://nantkwest.com/pipeline/
    If you read their site they were mostly involved in cancer "killer" drugs that help cancer drugs attach to cancer cells. The MSC work seems recent and rather opportunistic. Good luck to them as it just reinforces MSC treatments as strong approaches for immunological diseases. I expect that if they are eventually successful (which would appear to be quite some time from now), some interesting conversations around patents will take place.
    [Personal opinion only, based on reading their website]
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.01
Change
0.030(3.06%)
Mkt cap ! $1.153B
Open High Low Value Volume
$1.01 $1.04 99.0¢ $5.111M 5.050M

Buyers (Bids)

No. Vol. Price($)
2 211966 $1.01
 

Sellers (Offers)

Price($) Vol. No.
$1.02 136540 9
View Market Depth
Last trade - 16.10pm 16/08/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.